Rejuran S/I Regulatory Status: A Professional Sourcing Guide

Rejuran S/I, manufactured by Pharma Research in South Korea, is a polynucleotide (PN)-based product. As a category, polynucleotides function as biostimulators and skinboosters. Professionals evaluate such products based on their composition, intended professional application, and critically, their validated regulatory standing in various markets. This ensures suitability for clinic use and compliance with local health authority guidelines, which is paramount for responsible practice.

As an originator product from South Korea, Rejuran S/I's foundational regulatory approval lies with the Korean Ministry of Food and Drug Safety (KFDA). This certification is crucial for its manufacturing and distribution within South Korea. For wider international distribution, particularly within the European Union, a CE mark is often sought. The CE mark indicates that the product complies with EU health, safety, and environmental protection standards. [VERIFY: Confirm current KFDA approval and CE mark status for Rejuran S/I specifically as a medical device or equivalent classification.] This compliance is a key factor for clinics sourcing products for European markets, including those in the broader Skinbooster / biostimulator catalog.

Beyond KFDA and CE, the market access status of Rejuran S/I varies significantly by region. In the United States, obtaining FDA clearance or approval for polynucleotide products intended for aesthetic use requires specific clinical data and rigorous review. [VERIFY: Rejuran S/I is not currently FDA-approved for aesthetic indications in the US market, similar to many other international polynucleotide products.]

For regions like the GCC, LATAM, and APAC, local health authorities impose their own registration requirements. Professionals should expect their suppliers to demonstrate the product's registration or legal import status for their specific region. For example, similar considerations apply when sourcing other biostimulators like Sculptra (2 vials) or reviewing the market status of products like Lipo Lab Regulatory and Market Access Status: A Guide for Pr.

Parallel importing involves sourcing products outside of a manufacturer's official distribution channels, often leading to price differences but also potential compliance complexities. While not inherently illegal in all contexts, clinics must verify the authenticity, cold chain integrity, and regulatory compliance of parallel-imported products. Mismanaged parallel imports can compromise product quality and traceability, posing risks for both the clinic and its clients. When considering any sourcing, the provenance is as critical as the price point.

To mitigate risks, clinics should demand specific documentation from their suppliers when sourcing Rejuran S/I or any other aesthetic injectable. This includes certificates of authenticity, lot numbers, manufacturing dates, expiration dates, and proof of cold chain maintenance. For products like AMI Eyes, which also contain polynucleotides, similar verification processes are critical. Reputable distributors provide clear documentation of their regulatory compliance and supply chain integrity, offering transparency for professional buyers. This approach aligns with best practices for other injectables, as discussed in articles such as Re N Tox 100unit: Market Status and Professional Sourcing In.

For professional procurement, understanding the wholesale pricing structure is essential for inventory management and clinic profitability. Rejuran S/I typically carries an illustrative wholesale price of $157.8 per unit. Volume-based discounts are often applied, rewarding larger orders. For example, sourcing 11 units might yield a 4% discount, 21 units a 5% discount, 31 units a 6% discount, and orders of 51 units or more could receive an 8% discount. These tiers are designed to support clinics with varying operational scales and purchasing requirements.

Beyond initial regulatory checks, ongoing assurance of product quality is paramount. Professionals should prioritize suppliers who can provide comprehensive batch-specific documentation, ensuring that each unit of Rejuran S/I is traceable back to the manufacturer. This commitment to traceability and authenticity is a cornerstone of responsible sourcing practices in aesthetics. Clinics can refer to guides like How to Verify Genuine HYALMASS Dermal Filler for Professional for general principles of verifying product integrity, applicable across various aesthetic products.